Victor Chan is the Chief Financial Officer and Director of ACT Genomics Holdings Company Ltd. ACT Genomics is an Asian based cancer genomics diagnostics group and integrated biomarker solution leader. Mr Chan has over thirty years of experience in direct investment, corporate and financial management, private equity, investment banking, and corporate finance.

Since 2003, Mr. Chan has co-founded and co-managed several early-stage ventures. He was an investment partner at an Asian investment firm that specializes as an investor and incubator for early-stage technology and biomedical companies and acted as CFO for several portfolio companies. He was also previously the Managing Director of the Standard Chartered Bank Private Equity and Investment Bank and a Director and investment committee member of two Greater China private equity investment funds.

Mr. Chan, a Chartered Financial Analyst (CFA), has an MBA from the Chinese University of Hong Kong, an LLB from the University of London and a BA from the University of Hong Kong.